Investment ThemesDetailed Quotes
Infectious Disease
Watchlist
- 923.992
- -2.356-0.25%
Close Mar 26 16:00 ET
929.598High920.815Low
924.182Open926.348Pre Close128.62MVolume6Rise26.03P/E (Static)8.35BTurnover--Flatline0.39%Turnover Ratio2.23TMarket Cap12Fall2.19TFloat Cap
Constituent Stocks: 18Top Rising: GILD+1.28%
Sign in to post a comment
$Pfizer (PFE.US)$
ok i am in
ok i am in
1
1
I guess whoever is behind this didn't get the results they wanted. PFE only drops by about 29 cents. ![]()
![]()
![]()
![]()
Shorting over 100M, you better have something more than this. You are going to get the mother of all squeeze (MOAS)!
$Pfizer (PFE.US)$ $SPDR S&P 500 ETF (SPY.US)$
Shorting over 100M, you better have something more than this. You are going to get the mother of all squeeze (MOAS)!
$Pfizer (PFE.US)$ $SPDR S&P 500 ETF (SPY.US)$
1
1
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Pfizer (PFE.US)$
Added some shares at 25.39 to DCA.
Added some shares at 25.39 to DCA.
1
1
$Johnson & Johnson (JNJ.US)$
Game-Changing Clinical Data: New Cancer Drug Combo Extends Survival by 12+ Months
Game-Changing Clinical Data: New Cancer Drug Combo Extends Survival by 12+ Months
$Pfizer (PFE.US)$
Pharma businesses are resilient to economic recession.
Pharma businesses are resilient to economic recession.
3
Oh boy… there’s some money behind this… but usually, big money avoids dividend stocks. This isn’t normal…
4
$Johnson & Johnson (JNJ.US)$
Breakthrough Phase 3 Results: New Drug Shows Promise for Myasthenia Gravis, Including Pregnant Patients
Breakthrough Phase 3 Results: New Drug Shows Promise for Myasthenia Gravis, Including Pregnant Patients
$GlaxoSmithKline (GSK.US)$
Breakthrough: New UTI Antibiotic Blujepa Shows Superior Results in Clinical Trials
Breakthrough: New UTI Antibiotic Blujepa Shows Superior Results in Clinical Trials
$AstraZeneca (AZN.US)$
Major Breakthrough: AstraZeneca's TAGRISSO Extends Lung Cancer Survival to Nearly 5 Years
Major Breakthrough: AstraZeneca's TAGRISSO Extends Lung Cancer Survival to Nearly 5 Years
$Johnson & Johnson (JNJ.US)$
with yesterday’s breakout, it tocuhed the day bolinger. I expect more drop. hopefully in next several trading days.
with yesterday’s breakout, it tocuhed the day bolinger. I expect more drop. hopefully in next several trading days.
1
2
No comment yet
keene86 : long quan?